MRNS — Marinus Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $30.34m
- $43.35m
- $30.99m
- 29
- 35
- 13
- 14
Annual cashflow statement for Marinus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -54.1 | -67.5 | -98.8 | -19.8 | -141 |
| Depreciation | |||||
| Non-Cash Items | 5.8 | 8.27 | 14.2 | -87.4 | 20.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.59 | -2.04 | 28.7 | -6.09 | 2.17 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -48.6 | -60.9 | -55.5 | -113 | -118 |
| Capital Expenditures | -0.388 | 0 | -2.89 | -1.77 | -0.119 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.27 | -0.738 | 1.47 | 108 | -28.5 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 3.88 | -0.738 | -1.42 | 106 | -28.6 |
| Financing Cash Flow Items | — | — | -0.148 | 29.9 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 68 | 109 | 41.3 | 125 | 26.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 23.2 | 47.6 | -15.6 | 118 | -120 |